Close Menu

University of Vermont

Invitae is providing the testing services as part of the 12-month pilot, while patients will have the option to share their results with researchers though LunaDNA.

The firm is starting a trial that it anticipates will lead to an application for marketing clearance with the US Food and Drug Administration by next year.